3 results
The current proposal wants to examine the efficacy and cost-efficiency of a telemonitoring solution to improve medication adherence in chronic heart failure patients, to enhance the clinical state of the patients and to reduce health care…
The study will compare the overall survival (OS) between the MABp1 treated and placebo arms. Secondary endpoints will include change in lean body mass from screening to the cycle 5 assessment and change in quality of life.
The primary objective of the study is to evaluate the percentage of subjects with at least 35%spleen volume reduction in the fedratinib and the BAT arms.The secondary objectives are:• To evaluate the percentage of subjects with at least 50%…